Skip to main content
Top
Published in: Neurological Sciences 11/2015

01-11-2015 | Original Article

The association between clinically relevant anxiety and other non-motor symptoms in Parkinson’s disease

Authors: Si-Ming Jiang, Yong-Sheng Yuan, Qing Tong, Li Zhang, Qin-Rong Xu, Jian Ding, Ke-Zhong Zhang

Published in: Neurological Sciences | Issue 11/2015

Login to get access

Abstract

Anxiety disorders in patients with Parkinson’s disease (PD) are often missed due to an overlap with other non-motor symptoms. The relationships between anxiety and other non-motor symptoms in PD still remain unclear. We used the Hamilton anxiety rating scale and the Non-motor Symptoms Questionnaire to measure anxiety and the complex range of non-motor symptoms in 99 PD patients. The relationships between anxiety and other PD-related non-motor symptoms were examined through regression analyses. 25 % of PD patients were diagnosed with clinically relevant anxiety. Non-motor symptoms were more prominent in patients with anxiety. Depression, urinary disorders, and sleep disruption were the factors most likely to influence anxiety in PD. Our findings have revealed a strong interplay between anxiety and other non-motor symptoms of PD and have highlighted the need for a holistic approach towards the clinical treatment of this disabling condition.
Literature
1.
go back to reference Soh SE, Morris ME, McGinley JL (2011) Determinants of health-related quality of life in Parkinson’s disease: a systematic review. Parkinsonism Relat Disord 17:1–9CrossRefPubMed Soh SE, Morris ME, McGinley JL (2011) Determinants of health-related quality of life in Parkinson’s disease: a systematic review. Parkinsonism Relat Disord 17:1–9CrossRefPubMed
3.
go back to reference Dissanayaka NN, White E, O’Sullivan JD et al (2014) The clinical spectrum of anxiety in Parkinson’s disease. Mov Disord 29:967–975CrossRefPubMed Dissanayaka NN, White E, O’Sullivan JD et al (2014) The clinical spectrum of anxiety in Parkinson’s disease. Mov Disord 29:967–975CrossRefPubMed
4.
go back to reference Pontone GM, Williams JR, Anderson KE et al (2009) Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson’s disease. Mov Disord 24:1333–1338PubMedCentralCrossRefPubMed Pontone GM, Williams JR, Anderson KE et al (2009) Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson’s disease. Mov Disord 24:1333–1338PubMedCentralCrossRefPubMed
5.
go back to reference Shulman LM, Taback RL, Rabinstein AA et al (2002) Non-recognition of depression and other non-motor symptoms in Parkinson’s disease. Parkinsonism Relat Disord 8:193–197CrossRefPubMed Shulman LM, Taback RL, Rabinstein AA et al (2002) Non-recognition of depression and other non-motor symptoms in Parkinson’s disease. Parkinsonism Relat Disord 8:193–197CrossRefPubMed
6.
go back to reference Vazquez A, Jimenez-Jimenez FJ, Garcia-Ruiz P et al (1993) “Panic attacks” in Parkinson’s disease. A long-term complication of levodopa therapy. Acta Neurol Scand 87:14–18CrossRefPubMed Vazquez A, Jimenez-Jimenez FJ, Garcia-Ruiz P et al (1993) “Panic attacks” in Parkinson’s disease. A long-term complication of levodopa therapy. Acta Neurol Scand 87:14–18CrossRefPubMed
7.
go back to reference Lauterbach EC, Freeman A, Vogel RL (2003) Correlates of generalized anxiety and panic attacks in dystonia and Parkinson disease. Cogn Behav Neurol 16:225–233CrossRefPubMed Lauterbach EC, Freeman A, Vogel RL (2003) Correlates of generalized anxiety and panic attacks in dystonia and Parkinson disease. Cogn Behav Neurol 16:225–233CrossRefPubMed
8.
go back to reference Rutten S, Ghielen I, Vriend C et al (2015) Anxiety in Parkinson’s disease: symptom dimensions and overlap with depression and autonomic failure. Parkinsonism Relat Disord 21:189–193CrossRefPubMed Rutten S, Ghielen I, Vriend C et al (2015) Anxiety in Parkinson’s disease: symptom dimensions and overlap with depression and autonomic failure. Parkinsonism Relat Disord 21:189–193CrossRefPubMed
9.
go back to reference Hughes AJ, Daniel SE, Kilford L et al (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184PubMedCentralCrossRefPubMed Hughes AJ, Daniel SE, Kilford L et al (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184PubMedCentralCrossRefPubMed
10.
11.
go back to reference Fahn S (2005) Does levodopa slow or hasten the rate of progression of Parkinson’s disease? J Neurol 252 (suppl 4):IV37–IV42 Fahn S (2005) Does levodopa slow or hasten the rate of progression of Parkinson’s disease? J Neurol 252 (suppl 4):IV37–IV42
12.
go back to reference Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198CrossRefPubMed Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198CrossRefPubMed
13.
go back to reference Wenzelburger R, Zhang B, Pohle S (2002) Force overflow and levodopa-induced dyskinesias in Parkinson’s disease. Brain 125:871–879CrossRefPubMed Wenzelburger R, Zhang B, Pohle S (2002) Force overflow and levodopa-induced dyskinesias in Parkinson’s disease. Brain 125:871–879CrossRefPubMed
14.
go back to reference Leentjens AF, Dujardin K, Marsh L et al (2010) Anxiety rating scales in Parkinson’s disease: a validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale. Mov Disord 26:407–415CrossRef Leentjens AF, Dujardin K, Marsh L et al (2010) Anxiety rating scales in Parkinson’s disease: a validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale. Mov Disord 26:407–415CrossRef
15.
go back to reference Chaudhuri KR, Martinez-Martin P, Schapira AH et al (2006) International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease: the NMSQuest study. Mov Disord 21:916–923CrossRefPubMed Chaudhuri KR, Martinez-Martin P, Schapira AH et al (2006) International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease: the NMSQuest study. Mov Disord 21:916–923CrossRefPubMed
16.
go back to reference Jack M, Gorman MD (1996) Comorbid depression and anxiety spectrum disorders. Depress Anxiety 4:160–168CrossRef Jack M, Gorman MD (1996) Comorbid depression and anxiety spectrum disorders. Depress Anxiety 4:160–168CrossRef
17.
go back to reference Yamanishi T, Tachibana H, Oguru M et al (2013) Anxiety and Depression in Patients with Parkinson’s Disease. Intern Med 52:539–545CrossRefPubMed Yamanishi T, Tachibana H, Oguru M et al (2013) Anxiety and Depression in Patients with Parkinson’s Disease. Intern Med 52:539–545CrossRefPubMed
18.
go back to reference Kano O, Ikeda K, Cridebring D et al (2011) Neurobiology of depression and anxiety in Parkinson’s disease. Parkinson’s Disease 2011:143547–143551PubMedCentralPubMed Kano O, Ikeda K, Cridebring D et al (2011) Neurobiology of depression and anxiety in Parkinson’s disease. Parkinson’s Disease 2011:143547–143551PubMedCentralPubMed
19.
go back to reference Leentjens AF, Dujardin K, Marsh L et al (2011) Symptomatology and markers of anxiety disorders in Parkinson’s disease: a cross-sectional study. Mov Disord 26:484–492CrossRefPubMed Leentjens AF, Dujardin K, Marsh L et al (2011) Symptomatology and markers of anxiety disorders in Parkinson’s disease: a cross-sectional study. Mov Disord 26:484–492CrossRefPubMed
20.
go back to reference De Luka SR, Svetel M, Pekmezovic T et al (2014) When do the symptoms of autonomic nervous system malfunction appear in patients with Parkinson’s disease? Vojnosanit Pregl 71:346–351CrossRefPubMed De Luka SR, Svetel M, Pekmezovic T et al (2014) When do the symptoms of autonomic nervous system malfunction appear in patients with Parkinson’s disease? Vojnosanit Pregl 71:346–351CrossRefPubMed
21.
go back to reference Burnum JF, Hickam JB, Mc IH (1954) The effect of hypocapnia on arterial blood pressure. Circulation 9:89–95CrossRefPubMed Burnum JF, Hickam JB, Mc IH (1954) The effect of hypocapnia on arterial blood pressure. Circulation 9:89–95CrossRefPubMed
22.
go back to reference Berrios GE, Campbell C, Politynska BE (1995) Autonomic failure, depression and anxiety in Parkinson’s disease. Br J Psychiatry 166:789–792CrossRefPubMed Berrios GE, Campbell C, Politynska BE (1995) Autonomic failure, depression and anxiety in Parkinson’s disease. Br J Psychiatry 166:789–792CrossRefPubMed
23.
go back to reference Borek LL, Kohn R, Friedman JH (2006) Mood and sleep in Parkinson’s disease. J Clin Psychiatry 67:958–963CrossRefPubMed Borek LL, Kohn R, Friedman JH (2006) Mood and sleep in Parkinson’s disease. J Clin Psychiatry 67:958–963CrossRefPubMed
24.
go back to reference Leentjens AF, Dujardin K, Marsh L et al (2008) Anxiety rating scales in Parkinson’s disease:critique and recommendations. Mov Disord 23:2015–2025CrossRefPubMed Leentjens AF, Dujardin K, Marsh L et al (2008) Anxiety rating scales in Parkinson’s disease:critique and recommendations. Mov Disord 23:2015–2025CrossRefPubMed
Metadata
Title
The association between clinically relevant anxiety and other non-motor symptoms in Parkinson’s disease
Authors
Si-Ming Jiang
Yong-Sheng Yuan
Qing Tong
Li Zhang
Qin-Rong Xu
Jian Ding
Ke-Zhong Zhang
Publication date
01-11-2015
Publisher
Springer Milan
Published in
Neurological Sciences / Issue 11/2015
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-015-2320-0

Other articles of this Issue 11/2015

Neurological Sciences 11/2015 Go to the issue